Gilead Sciences
GILD
1,632 hedge funds and large institutions have $98.3B invested in Gilead Sciences in 2016 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 737 increasing their positions, 659 reducing their positions, and 99 closing their positions.
20% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 99
12% more repeat investments, than reductions
Existing positions increased: 737 | Existing positions reduced: 659
0% more funds holding
Funds holding: 1,630 → 1,632 (+2)
6% less call options, than puts
Call options by funds: $1.74B | Put options by funds: $1.84B
2.93% less ownership
Funds ownership: 83.28% → 80.35% (-2.9%)
15% less capital invested
Capital invested by funds: $115B → $98.3B (-$16.9B)
16% less funds holding in top 10
Funds holding in top 10: 225 → 188 (-37)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$408M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
+$275M |
| 3 |
Barclays
London,
United Kingdom
|
+$239M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$167M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.99B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.1B |
| 3 |
O
OppenheimerFunds
New York
|
-$573M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$543M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$538M |
GILD Hedge Fund Activity: Q1 2016 in Review
1,632 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2016, worth a combined $98.3B — down 15% from $115B a quarter earlier.
Buyers outnumbered sellers: 119 funds opened new GILD positions and 99 closed out — a net gain of 20 holders — while 737 added to existing stakes and 659 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $408M. The largest seller was Capital Research Global Investors, cutting an estimated $1.99B.
- 1,632 institutional investors held Gilead Sciences (GILD) as of Q1 2016, up from 1,630 in Q4 2015.
- Funds reported $98.3B of Gilead Sciences stock for Q1 2016, down 15% quarter-over-quarter.
- 119 funds opened new Gilead Sciences positions in Q1 2016 and 99 closed out, a net change of +20 holders.
- The largest Gilead Sciences buyer in Q1 2016 was JP Morgan Chase, an estimated $408M added.
- The largest Gilead Sciences seller in Q1 2016 was Capital Research Global Investors, an estimated $1.99B sold.
Based on aggregated 13F filings for Q1 2016.